Immune & Gut

Larazotide Acetate

Also known as Larazotide, AT-1001, INN-202

An oral tight-junction regulator studied for intestinal barrier integrity

Larazotide acetate is an orally active, locally acting octapeptide studied for its ability to help keep the tight junctions between intestinal cells closed. It is explored as a targeted tool for supporting gut barrier integrity within a physician-guided plan.

Larazotide Acetate visual

How It Works

Larazotide acetate is a small peptide that works right at the surface of the gut lining rather than being absorbed into the bloodstream. Its job is to help the microscopic seals between intestinal cells, called tight junctions, stay closed the way they should. When those seals loosen, the barrier becomes more permeable and lets through material it normally keeps out; larazotide is studied for helping that barrier stay intact. Because it acts locally in the intestine, it is being explored as a focused approach to gut barrier support under medical guidance.

The Science & Mechanism

Larazotide acetate is a synthetic octapeptide (Gly-Gly-Val-Leu-Val-Gln-Pro-Gly) originally derived from a fragment of the zonula occludens toxin produced by Vibrio cholerae. It acts as an antagonist of the zonulin pathway, the primary physiological system that regulates intestinal tight junctions. Zonulin signaling drives PKC-dependent rearrangement of the actin cytoskeleton and activation of myosin light-chain kinase (MLCK), which places tension on the junctional complex and pulls apart tight-junction proteins such as occludin, ZO-1, and the claudins, increasing paracellular permeability. Research describes larazotide as promoting the reassembly and tightening of these junctions, in part by dampening actin rearrangement and MLCK-driven contraction, helping restore a more organized barrier. Because it is not meaningfully absorbed, its activity is concentrated at the luminal surface of the epithelium, where it is thought to reduce the passage of luminal antigens and other material across the barrier. It has been most extensively investigated in celiac disease as an adjunct to a gluten-free diet, where a leaky barrier is thought to allow gluten-derived fragments to reach the immune system, and it advanced into late-stage clinical trials in that setting.

Potential Benefits

  • May support the integrity of the intestinal barrier
  • Studied for its role in helping tight junctions between gut cells stay closed
  • May help support a healthy response to intestinal permeability
  • Explored for its ability to limit passage of luminal antigens across the gut lining
  • May complement gut-focused and immune-support protocols
  • Studied for its localized, non-absorbed action within the intestine

Who It May Be Best Suited For

  • Individuals focused on supporting intestinal barrier integrity
  • Those exploring gut permeability and digestive-comfort support
  • People interested in gut-directed immune balance
  • Clients seeking a locally acting complement to gut-focused protocols

Important Considerations

Larazotide acetate is intended for use only under the supervision of a qualified physician, and the right approach is individualized to your labs, health history, and goals. It has not been evaluated by the FDA for these uses, is not a substitute for diagnosis or treatment of any medical condition, and individual results vary. Dr. Rob reviews your candidacy, formulation, and protocol one-on-one to help it fit appropriately into your overall plan.

gut health intestinal barrier tight junction immune balance peptide gut permeability
Educational information only. These pages are for educational purposes and are not medical advice. Care is offered only under the direct supervision of a licensed physician. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Continue Exploring

More in Peptides

Care Built Around You

Curated 30-minute 1:1 consultations with Dr. Rob - far beyond a five-minute visit. Let's build a plan designed around your goals.